Your institution may have access to this item. Find your institution then sign in to continue.

Title: Letter: metformin reduces the risk of hepatocellular carcinoma in diabetic patients.
Authors: Huo, Rong‐Rui; Liang, Jing‐Rong; He, Feng‐Yi; Xu, Bin‐Rong; Ma, Liang; Yuan, Wei‐Ping
Abstract: LINKED CONTENT This article is linked to Vilar‐Gomez et al and Vilar‐Gomez and Chalasani papers. To view these articles, visit https://doi.org/10.1111/apt.15331 and https://doi.org/10.1111/apt.15486.
Subjects: METFORMIN; HEPATOCELLULAR carcinoma; LETTERS
Publication: Alimentary Pharmacology & Therapeutics, 2019, Vol 50, Issue 7, p837
ISSN: 0269-2813
Publication type: Academic Journal
DOI: 10.1111/apt.15467

We found a match

Letter: metformin reduces the risk of hepatocellular carcinoma in diabetic patients.